M-LANSOPRAZOLE
Identification of M-Lansoprazole
| No description |
Google image searchProduct monograph
Active ingredient
lansoprazole, 30 MG
DIN: 02489813
Dosage form(s): CAPSULE (DELAYED RELEASE)
Route(s) of administration: ORAL
Schedule: Prescription
Company: MANTRA PHARMA INC
Date: 13-DEC-2019
ATC:
- A02 — DRUGS FOR ACID RELATED DISORDERS (ATC, ATC/DDD, )
- A02B — DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) (ATC, ATC/DDD)
- A02BC — Proton pump inhibitors (ATC, ATC/DDD)
- A02BC03 — LANSOPRAZOLE (ATC/DDD)
Reference brand drug: Prevacid
Pharmaceutical standard: USP
